AB

Absci Corporation Common Stock

ABSI Q1 2026

Absci’s shares moved marginally (+0.5%) following its Q1 2026 update, indicating that while investors found the reported progress in the ABS-201 clinical program broadly in line with what was expected, there was no clear catalyst to drive a meaningful re-rate.

AC

Acerinox, S.A.

ACX.MC Q1 2026

Acerinox’s Q1 results were broadly in line with expectations, with a mixed operational performance and no clear catalysts to drive the stock higher, reflected by a modest -0.3% share price decline. Despite a 6% sales increase and volume growth, market uncertainties and only gradual improvement in key regions tempered enthusiasm.

AL

ALX Oncology Holdings Inc.

ALXO Q1 2026

ALX Oncology reported clinical progress consistent with expectations, including updated biomarker data for evorpacept and ongoing dose escalation for ALX2004, but the lack of market movement suggests investors found no new material catalysts or surprises in the quarter.

AM

AMN Healthcare Services, Inc.

AMN Q1 2026

AMN Healthcare's stock surged 34.8% following a first quarter that notably beat expectations on revenue and margin, driven by exceptional execution amid significant labor disruption events and strong performance in Nurse and Allied Solutions.

AR

Arcturus Therapeutics Holdings Inc.

ARCT Q1 2026

Shares fell 3.0% as investors appeared unsettled by a cautious outlook and the early-stage nature of clinical progress, with no new commercial or financial guidance provided to offset ongoing development risks.

AR

Array Technologies, Inc.

ARRY Q1 2026

Array Technologies’ shares rose modestly by 1.9% following Q1 results that showed stable revenue and margin improvement driven by execution and volume gains, but the market reaction indicates cautious optimism rather than enthusiasm amid offsetting factors such as lower average selling prices.

BA

BROOKFIELD ASSET MANAGEMENT INC

BAM Q1 2026

Brookfield Asset Management’s shares were little changed post-earnings, reflecting a largely in-line report with steady fundraising and fee-related earnings growth but lacking a clear upside catalyst to drive a stronger move.

BB

Barings BDC, Inc.

BBDC Q1 2026

Shares declined 3.3% following the quarter as investors were disappointed by net investment income compression and a modest net asset value decline driven by legacy asset write-downs, signaling caution on earnings power amid ongoing portfolio rotation.

BB

BB Seguridade Participacoes S.A.

BBSEY Q1 2026

Shares declined modestly by 0.4% following Q1 results, reflecting investor caution amid flat premiums and a cautious commercial outlook despite solid net income growth and strong investment income.

BE

Better Home & Finance Holding Company Class A Common Stock

BETR Q1 2026

Better Home & Finance shares edged up 1.7% after Q1 results that showed solid volume growth but were tempered by slower-than-expected forward momentum due to macroeconomic headwinds and cautiously moderated guidance.

BG

Bank of Georgia Group PLC

BGEO.L Q1 2026

Shares declined 1.5% following the Q1 report as investors appeared cautious despite solid underlying growth, likely reflecting concerns over margin pressure from FX income weakness and the cautious outlook on costs amidst revenue growth.

BX

Blackstone Secured Lending Fund

BXSL Q1 2026

Shares declined 2.3% following the quarter as investor concerns centered on modest portfolio credit deterioration, mark-to-market NAV compression, and new additions to nonaccruals despite stable income and dividend coverage.

CR

Crinetics Pharmaceuticals, Inc.

CRNX Q1 2026

Crinetics shares fell 16% as investors reacted negatively to cautious and uncertain outlook signals, despite ongoing patient enrollments and market expansion efforts. The weak market response reflects concerns over commercial execution pacing and the company’s guarded tone on growth sustainability.

DE

Diversified Energy Company PLC

DEC Q1 2026

Shares were largely unchanged following the quarter, with the market digesting the announcement of a sizable asset acquisition structured as an off-balance-sheet deal that preserves liquidity and equity. The modest 0.4% gain reflects a neutral reception as investors weighed the benefits of the transaction against limited near-term earnings impact.

FI

FIGS, Inc.

FIGS Q1 2026

Shares fell sharply by 22.3% as investors reacted negatively to cautious outlook signals and margin pressures despite reported revenue growth.

FR

JFrog Ltd.

FROG Q1 2026

JFrog shares surged 21% post-earnings, driven primarily by cloud revenue growth and robust enterprise adoption that surpassed expectations, reflecting investor enthusiasm for the company’s positioning amid accelerating AI-fueled software supply chain activity.

GO

Gogo Inc.

GOGO Q1 2026

Gogo’s stock fell 9.9% following the earnings release, driven primarily by investor concerns over ongoing attrition in the GEO segment and a cautious outlook on legacy product transitions despite progress in next-generation 5G and LEO deployments.

GP

GeoPark Limited

GPRK Q1 2026

GeoPark’s shares rose 6.1% following a quarter that showcased better-than-expected operational execution and improved pricing, driving significant margin expansion and a reinforced financial position.

GR

Grifols, S.A.

GRF.MC Q1 2026

Shares declined 1.2% following the quarter, reflecting investor caution despite results largely in line with prior guidance and steady margins, with market focus likely on the cautious outlook and incremental execution challenges ahead. The market reaction suggests investors remain cautious on the outlook and any incremental pressure on margin expansion or growth acceleration.

HA

Haemonetics Corporation

HAE Q4 2026

Shares fell 3.9% as investors reacted negatively to persistent weakness and declines in the interventional technologies segment, overshadowing solid growth elsewhere and a cautious stance on near-term growth drivers.

HA

Hannon Armstrong Sustainable Infrastructure Capital, Inc.

HASI Q1 2026

The stock declined 3.5% following earnings as investors reacted negatively to deceleration concerns signaled by cautious commentary on geopolitical volatility and energy market challenges, despite stable financial metrics and maintained guidance.

HH

Howard Hughes Holdings Inc.

HHH Q1 2026

Howard Hughes Holdings’ shares inched up 1.2% after earnings, reflecting a generally stable reaction as the company navigates its business model transition without providing annual guidance. While master planned communities delivered solid land sales and MPC EBT growth, the absence of explicit annual guidance and the lumpiness of condo profits kept the market cautious.

IB

Installed Building Products, Inc.

IBP Q1 2026

Installed Building Products shares dropped 6.3% following a revenue decline and pronounced new residential sales weakness that outweighed commercial growth, underscoring soft demand and margin pressure concerns among investors.

II

Information Services Group, Inc.

III Q1 2026

ISG’s shares declined modestly by 0.7% following the Q1 report, reflecting a lukewarm market response despite revenue growth and margin expansion, indicating investor reservations amid mixed regional trends and cautious near-term visibility.

IN

Inseego Corp.

INSG Q1 2026

Shares declined 2.0% after Q1 results as investors took note of ongoing execution challenges in mobile product launches and disruption in the FWA segment, tempering growth prospects despite revenue growth and margin stability.

IN

Inter & Co, Inc.

INTR Q1 2026

Shares of Inter & Co dropped 7.4% following Q1 results as investors reacted to cautious outlook signals and margin pressures, despite ongoing loan portfolio growth. The market clearly expressed concern over decelerating momentum and margin compression hinted in the financial commentary.

IR

IRSA Inversiones y Representaciones Sociedad Anónima

IRS Q3 2026

The stock edged up slightly by 0.3% following Q3 results that showed resilient rental income despite softer tenant sales and consumption trends; no clear catalyst emerged to drive a stronger market response.

KO

Eastman Kodak Company

KODK Q1 2026

Eastman Kodak's shares dropped sharply by 25.2% following earnings as investors were likely disappointed by margin compression and a cautious outlook masked by stable headlines. Despite revenue growth, the market reacted negatively to underlying pressures in margins and ongoing inflationary challenges.

LY

Lyft, Inc.

LYFT Q1 2026

Lyft shares declined 2.0% following a quarter that showed growth but offered a cautious outlook and no meaningful upward revision to guidance, leaving investors wary amid intensifying competitive and regulatory pressures.

NK

Nektar Therapeutics

NKTR Q1 2026

Nektar’s shares fell 5.5% following the earnings release, reflecting investor disappointment primarily with cautious outlook and elongated timelines for Phase III data readouts, which delay potential commercialization and revenue generation.

OM

Outset Medical, Inc.

OM Q1 2026

Shares declined 1.4% after Outset Medical reported a modest revenue decline and continued lumpiness in capital sales, which dampened top-line growth and raised caution on near-term momentum despite margin expansion and a stable outlook.

ON

Orion Office REIT Inc.

ONL Q1 2026

Orion Properties’ shares edged up modestly by 1.1% following a quarter marked by continued portfolio stabilization but offset by a decline in revenue and a wider net loss, reflecting mixed investor sentiment on the pace of recovery and bottom-line pressures.

OP

Opendoor Technologies Inc.

OPEN Q1 2026

Opendoor’s stock fell 8.8% after earnings as investors reacted to cautious commentary on forward growth despite margin improvements and sizeable contract growth, signaling concerns about sustainable momentum and outlook credibility.

PA

Payoneer Global Inc. Common Stock

PAYO Q1 2026

Payoneer’s Q1 results impressed with sharply accelerating B2B volume growth and expanding core profitability, driving a 6.2% stock increase as investors rewarded better-than-expected execution across key metrics.

PD

PDF Solutions, Inc.

PDFS Q1 2026

PDF Solutions’ shares jumped 15.5% following stronger-than-expected bookings and robust revenue growth, driven primarily by significant demand for their Exensio and Cimetrix products, alongside growing secureWISE adoption.

PU

PubMatic, Inc.

PUBM Q1 2026

PubMatic shares declined 3.5% post-earnings, reflecting investor disappointment driven primarily by caution in forward guidance and indications of margin pressure despite revenue growth.

RE

The RealReal, Inc.

REAL Q1 2026

Shares of The RealReal plunged 19.6% following earnings as investors reacted negatively to signs of guidance caution and deceleration in key engagement metrics, overshadowing ongoing margin expansion and sales channel initiatives. While operational improvements and strategic pillars provide a foundation, the pronounced share price decline suggests the market is signaling skepticism on forward growth visibility and guidance clarity.

RI

RCI Hospitality Holdings, Inc.

RICK Q1 2026

Shares dropped 4.1% as investors reacted to disappointing margin compression and a cautious outlook driven by ongoing net charges and declining profitability in the Bombshells segment despite stable revenues.

RO

Laboratorios Farmaceuticos Rovi, S.A.

ROVI.MC Q1 2026

ROVI’s shares declined 1.2% following the release of weak heparin sales and a revised cautious outlook, which tempered otherwise stable revenue and margin expansion. Investors appear concerned by ongoing headwinds in the key heparin division and moderated CDMO growth expectations.

RX

RxSight Inc. Common Stock

RXST Q1 2026

RxSight shares fell 2.6% post-earnings as investors responded cautiously to persistent volume weakness and elevated operating expenses despite reiteration of full-year guidance.

SE

Senseonics Holdings, Inc.

SENS Q1 2026

The stock gained 7.6% post-earnings, reflecting investor approval of revenue growth, margin expansion, and upward guidance. Strong execution on commercial integration and new market penetration appear to have outweighed any lingering skeptics.

SG

Sweetgreen, Inc.

SG Q1 2026

Shares declined 1.9% following the quarter, reflecting investor disappointment with the significant comparable sales decline and ongoing margin pressure amid a challenging operating environment, despite early signs of operational improvements.

SK

The Beauty Health Company Class A Common Stock

SKIN Q1 2026

SkinHealth Systems’ stock plunged 26.4% following a disappointing earnings report driven primarily by a lowered full-year revenue outlook and continued softness in device placements amid challenging macro conditions and intensified competition.

SO

Saturn Oil & Gas Inc.

SOIL.TO Q1 2026

Saturn’s stock rose modestly by 1.5% following Q1 results that generally met expectations, with volumes, cash flow, and debt reduction progressing as planned; however, the muted market reaction suggests investors remain cautious given seasonal cost pressures and limited oil price exposure earlier in the quarter.

SY

Synaptics Incorporated

SYNA Q3 2026

Synaptics rallied 19.6% post-earnings as accelerating IoT revenue growth and strong margin performance outweighed any residual concerns, signaling investor confidence in its expanding Edge AI product pipeline and design wins.

TI

Telecom Italia S.p.A.

TIT.MI Q1 2026

TIM’s shares edged up 1.3% following Q1 results that largely aligned with expectations, reflecting steady execution despite ongoing MVNO-related revenue and EBITDA headwinds and a cautious, back-end-loaded outlook for the year.

TX

Torex Gold Resources Inc.

TXG.TO Q1 2026

Torex Gold’s shares rose modestly by 1.1% following Q1 results that showed operational challenges with lower grades and elevated costs but were offset by strong free cash flow and successful debt elimination. The market reaction implies investors viewed the quarter as in line with expectations without clear surprises.

WE

WELL Health Technologies Corp.

WELL.TO Q1 2026

WELL Health’s stock declined 1.9% following the quarter, reflecting moderate investor caution as the overall results showed strong top-line growth but persistent headwinds from the Circle Medical segment and ongoing revenue deferrals that cloud comparability and near-term outlook.

WE

Western Midstream Partners, LP

WES Q1 2026

Western Midstream Partners shares rose modestly by 1.1% following quarterly results that delivered solid operational progress and a strategic acquisition, though the market’s tepid reaction suggests investors remain cautious, likely awaiting formal guidance updates and clarity on commodity-driven volume sustainability.

YP

YPF Sociedad Anonima

YPFD.BA Q1 2026

YPF’s positive 6% market reaction reflects investor approval of its outperformance on volume growth, margin expansion, and free cash flow generation despite cautious signaling on local fuel pricing amid demand softness.